Free tool
Stocks near their 52-week high
We cover 142 companies trading within 5% of their own 52-week high. The median market value in the group is $6.06B. Across the group, the median move over the past trading day is 0.00%. 99% of the 137 with a 200-day average trade above it. Price change over the past year runs from +7.3% to +188.8% across the middle 80 percent of the group, with a median of +41.5%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
142 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% |
| JNJB34.SA | Johnson & Johnson | 92.80 BRL | +2.16% | +24.99% | +47.82% |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% |
| ABBV34.SA | AbbVie Inc. | 84.88 BRL | −0.29% | +9.50% | +21.88% |
| RHO.DE | Roche Holding AG | 405.40 EUR | +2.01% | +14.00% | +41.42% |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% |
| GIS.DE | Gilead Sciences, Inc. | 126.78 EUR | +7.51% | +23.41% | +33.64% |
| PFE | Pfizer Inc. | $28.30 | +12.08% | +16.16% | +18.72% |
| PFE.DE | Pfizer Inc. | 24.44 EUR | +10.09% | +18.44% | +22.96% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | 475.00 EUR | +10.21% | +23.55% | +41.64% |
| VRTX | Vertex Pharmaceuticals Incorporated | $547.29 | +11.60% | +21.05% | +40.66% |
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | 70.98 BRL | +20.22% | +2.34% | +33.80% |
| REGN | Regeneron Pharmaceuticals, Inc. | $814.79 | +17.21% | +5.24% | +39.36% |
| TAK | Takeda Pharmaceutical Company Limited | $18.23 | +4.05% | +16.71% | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | 5,791.00 JPY | −0.96% | +19.85% | +36.03% |
| C1AH34.SA | Cardinal Health, Inc. | 1,234.64 BRL | +2.68% | +6.79% | +52.41% |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% |
| TEVA | Teva Pharmaceutical Industries Limited | $37.92 | +19.73% | +22.52% | +110.08% |
| A | Agilent Technologies, Inc. | $155.08 | +10.35% | +12.88% | +31.46% |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% |
| WAT | Waters Corporation | $414.17 | +7.88% | +8.43% | +40.57% |
| 4578.T | Otsuka Holdings Co., Ltd. | 12,260.00 JPY | +6.56% | +35.48% | +57.62% |
| RPRX | Royalty Pharma plc | $61.80 | +3.05% | +60.57% | +74.00% |
| D1EX34.SA | DexCom, Inc. | 9.21 BRL | +28.45% | +22.96% | +9.64% |
| DXCM | DexCom, Inc. | $88.96 | +18.85% | +33.69% | +16.47% |
| DC4.DE | DexCom, Inc. | 77.60 EUR | +16.52% | +37.44% | +21.06% |
| BIIB | Biogen Inc. | $221.07 | +7.52% | +24.32% | +62.12% |
| C1NC34.SA | Centene Corporation | 340.30 BRL | −2.49% | +53.30% | +116.61% |
| IDP.DE | Biogen Inc. | 190.12 EUR | +0.21% | +26.49% | +65.32% |
| ROIV | Roivant Sciences Ltd. | $36.75 | +8.60% | +67.58% | +206.51% |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% |
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% |
| THC | Tenet Healthcare Corporation | $274.19 | +4.40% | +37.47% | +50.70% |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% |
| IPN.PA | Ipsen S.A. | 166.00 EUR | +1.41% | +42.98% | +40.80% |
| SOLV | Solventum Corporation | $91.53 | +6.22% | +15.83% | +25.57% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | 36.47 AUD | +5.19% | +12.67% | +11.27% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +7.58% | +17.51% | +12.65% |
| 7733.T | Olympus Corporation | 2,162.50 JPY | +16.11% | +8.42% | +27.06% |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% |
| ORNBV.HE | Orion Oyj | 80.80 EUR | −1.76% | +29.38% | +21.01% |
| ORNAV.HE | Orion Oyj | 80.50 EUR | −1.83% | +29.71% | +21.27% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.53% | +10.68% | +1.80% |
| TECH | Bio-Techne Corporation | $72.38 | +0.43% | +21.73% | +29.33% |
| PRAX | Praxis Precision Medicines, Inc. | $377.37 | +27.57% | +31.76% | +704.28% |
| KYMR | Kymera Therapeutics, Inc. | $125.55 | +18.26% | +72.55% | +197.09% |
| HSIC | Henry Schein, Inc. | $90.38 | +5.45% | +17.65% | +31.02% |
| RHCPA.AX | Ramsay Health Care Limited | 108.65 AUD | +0.60% | +1.45% | +1.45% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +62.83% |
| TWST | Twist Bioscience Corporation | $150.06 | +69.46% | +363.29% | +451.89% |
| DEMANT.CO | Demant A/S | 284.60 DKK | +0.21% | +33.36% | +17.12% |
| IMVT | Immunovant, Inc. | $43.89 | +12.83% | +69.39% | +189.13% |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% |
| SRRK | Scholar Rock Holding Corporation | $60.04 | +21.61% | +40.28% | +74.18% |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% |
| HNGE | Hinge Health, Inc. | $90.50 | +20.27% | +98.64% | +56.66% |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% |
| E2XE34.SA | Exelixis, Inc. | 137.40 BRL | −2.25% | +23.92% | +23.92% |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% |
| TFX | Teleflex Incorporated | $138.74 | +3.38% | +13.97% | +8.06% |
| SHC | Sotera Health Company | $19.54 | +10.02% | +10.46% | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $90.54 | +15.65% | +4.73% | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $29.58 | +13.73% | +12.51% | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $26.36 | +1.78% | +42.49% | +93.26% |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $34.95 | +6.91% | +81.01% | +50.93% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 23.00 EUR | +3.84% | +58.22% | +1.26% |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% |
| PGEN | Precigen, Inc. | $7.42 | +34.18% | +73.36% | +61.66% |
| PHVS | Pharvaris N.V. | $37.00 | +9.97% | +39.73% | +55.59% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| ADUS | Addus HomeCare Corporation | $120.71 | +1.25% | +13.26% | +4.50% |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% |
| MD | Pediatrix Medical Group, Inc. | $26.95 | +0.34% | +26.59% | +56.87% |
| SEM | Select Medical Holdings Corp | $16.51 | −0.12% | +12.30% | +28.14% |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,970.00 JPY | +5.37% | +57.28% | +79.12% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| PYC.AX | PYC Therapeutics Limited | 2.25 AUD | +38.46% | +35.95% | +74.42% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | 57.60 BRL | +8.15% | +25.08% | +298.89% |
| LBRX | LB Pharmaceuticals Inc | $48.17 | +37.85% | +135.64% | +178.41% |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% |
| MGTX | MeiraGTx Holdings plc | $14.92 | +26.23% | +91.04% | +100.54% |
| DRTS | Alpha Tau Medical Ltd. | $14.96 | +29.52% | +209.73% | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | 3,410.00 JPY | −3.26% | +3.54% | +1.90% |
| NUTX | Nutex Health Inc. | $195.92 | +31.46% | +32.21% | +118.22% |
| AVNS | Avanos Medical Inc | $24.99 | +0.04% | +123.52% | +110.53% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | 88.80 BRL | −0.54% | +35.66% | +35.66% |
| ABUS | Arbutus Biopharma Corporation | $5.19 | +17.69% | +8.81% | +42.19% |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% |
| B2RK34.SA | Bruker Corporation | 30.63 BRL | −0.49% | +63.27% | +63.27% |
| TALK | Talkspace, Inc. | $5.25 | +0.77% | +49.57% | +93.73% |
| AMS.L | Advanced Medical Solutions Group plc | 281.50 GBP | +0.36% | +29.14% | +38.01% |
| UU8.F | Neurogene Inc. | 33.20 EUR | +21.17% | +29.18% | +165.60% |
| 7575.T | Japan Lifeline Co., Ltd. | 1,565.00 JPY | +7.93% | +0.59% | +12.02% |
| GUD.TO | Knight Therapeutics Inc. | 9.76 CAD | −0.81% | +65.14% | +50.39% |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $17.02 | +20.20% | +49.43% | +70.03% |
| 6197.T | Solasto Corporation | 1,118.00 JPY | +0.63% | +30.15% | +136.68% |
| EOLS | Evolus, Inc. | $8.78 | +41.16% | +30.65% | +15.83% |
| 2664.T | Cawachi Limited | 3,760.00 JPY | +8.20% | +28.43% | +38.25% |
| 7979.T | Shofu Inc. | 2,321.00 JPY | +6.76% | +30.43% | +21.34% |
| 3151.T | Vital KSK Holdings, Inc. | 1,670.00 JPY | −2.51% | +21.29% | +40.44% |
| PBYI | Puma Biotechnology, Inc. | $9.16 | +14.93% | +58.75% | +79.61% |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% |
| FRX.TO | Fennec Pharmaceuticals Inc. | 17.00 CAD | +21.86% | +63.30% | +36.00% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | 2,623.00 JPY | +5.13% | +30.89% | +27.04% |
| IKT | Inhibikase Therapeutics, Inc. | $2.49 | +7.79% | +27.69% | +39.11% |
| LIK.DE | LIMES Schlosskliniken AG | 570.00 EUR | −0.87% | +58.33% | +70.66% |
| LOVE.TO | Cannara Biotech Inc. | 1.99 CAD | +5.29% | +11.80% | +11.80% |
| 4599.T | StemRIM | 350.00 JPY | +21.53% | +32.08% | +14.75% |
| 004080.KS | Shinhung Co., Ltd | 14,080.00 KRW | +0.28% | +0.57% | +2.54% |
| RLYB | Rallybio Corporation | $16.88 | +4.49% | +198.44% | +257.63% |
| INIFY.OL | INIFY Laboratories AB | 7.95 NOK | −3.05% | +65.63% | +44.55% |
| 7702.T | JMS Co.,Ltd. | 459.00 JPY | +1.32% | +5.64% | +6.20% |
| RNXT | RenovoRx, Inc. | $1.49 | +64.28% | +78.44% | +61.08% |
| 7091.T | Living Platform,Ltd. | 1,285.00 JPY | +7.98% | +22.20% | +34.42% |
| 7129.T | Miahelsa Holdings Corporation | 1,155.00 JPY | +0.09% | +2.17% | +4.87% |
| 9220.T | FB Care Service Co.,Ltd. | 1,287.00 JPY | +3.96% | +12.06% | +11.55% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +50.00% |
| GXI.SW | Gerresheimer AG | 25.28 CHF | −1.71% | +2.10% | +2.10% |
| LONN.SW | Lonza Group AG | 587.80 CHF | +2.26% | +10.90% | +4.28% |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% |
| RO.SW | Roche Holding AG | 379.00 CHF | +1.99% | +17.47% | +41.81% |
| ROP.SW | Roche Holding AG | 373.80 CHF | +3.35% | +18.35% | +47.60% |
| SDZ.SW | Sandoz Group AG | 73.54 CHF | +9.01% | +30.08% | +47.80% |
| TECN.SW | Tecan Group AG | 193.30 CHF | +4.20% | +48.97% | +19.14% |
| YPSN.SW | Ypsomed Holding AG | 407.20 CHF | +4.36% | +24.15% | +4.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.